Brushing aside last two days dismal performance,BSE Sensex today opened to a good start by rising 113.76 points or 0.58% to 19,724.24 in early trade.
Shares of GlaxoSmithKline,Tata Communications and Wockhardt were leading the gainers tally in opening trade while Infosys,TCS,HDFC and Ultratech Cements were trading in red.
STOCK MARKETS LINKS
The 50-share wide exchange NSE Nifty too was up 26.60 points or 0.45 % to 5,965.90 in opening trade. Bank Nifty was up 84.40 points or 0.68 % to 12,486.50.
The 30-share benchmark sensitive index had closed at 19,610.48,down 149.82 points or 0.76 per cent yesterday.
Similarly,the NSE Nifty declined by 46.65 points or 0.78 per cent,at 5,939.30 on Monday.
Indian stocks to watch-June 04
(Reuters): India cabinet may meet to decide on Vodafone tax dispute. (1400 GMT)
Delhi High Court will hear a petition by US drugmaker Merck & Co,which has accused Glenmark Pharma of patent infringement on two diabetes drugs.
India’s cbank clarifies rules for new bank licences.
EU to fine Lundbeck,others for blocking generic drugs,including India’s Ranbaxy.
Idea in talks with Axiata to sell tower business.
DoT slaps 12.63 billion Indian rupees ($222.36 million) fine on Vodafone for underreporting revenues.
Government defines “group company” to remove FDI ambiguities.
Steel Authority Of India’s production rises 11 pct in May.
Wipro acquires minority stake in Axeda Corp for $5 mln.
State Bank Of India cuts interest rate on bulk deposits.
India’s May gold imports jump,more curbs possible.
India cbank does not target any particular exchange rate,says chief.
Rs 55 billion loans to MFIs may become NPAs by September-end.
GLOBAL MARKETS ROUNDUP
Nifty futures on the Singapore Exchange are 0.09 percent down and the MSCI-Asia Pacific index excluding Japan is 0.18 percent higher.
Asian shares recovered from their lowest in about six months on Tuesday as weak new U.S. manufacturing data eased worries about the Federal Reserve’s stimulus programme,although investors were cautious before a more important jobs report later in the week.
U.S. stocks rose on Monday as weaker-than-expected factory activity supported views the Federal Reserve will keep economic stimulus in place,while gains in Merck & Co lifted drug companies.